In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies

Experimental Neurology

Volumn 166, Issue 2, 2000, Pages 324-333

  Gai, W P ^a   Yuan, H X ^a   Li, X Q ^b   Power, J T H ^a   Blumbergs, P C ^c   Jensen, P H ^d  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Dementia with Lewy bodies; Lewy body; Lipid; Parkinson's disease; Ubiquitin; synuclein

Indexed keywords

ALPHA SYNUCLEIN; LIPID; UBIQUITIN;

ARTICLE; BRAIN CORTEX; CELL INCLUSION; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; LEWY BODY; LIPID ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0033669319     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7527     Document Type: Article

References (48)

1. Mice lacking α-synuclein display functional defcits in the nigrostriatal dopamine system
2. NACP/ α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
3. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
4. Degradtion of α-synuclein by proteasome
5. The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease)
6. Neuropathological stageing of Alzheimer-related changes
7. Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by α-synuclein immunocytochemistry
8. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
9. The ubiquitin-mediated proteolytic pathway
10. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
11. Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited: NAC and α-synuclein are not associated with Aβ amyloid
12. Relationships between Lewy bodies and pale bodies in Parkinson's disease
13. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes
14. Sphingomyelin in Lewy inclusion bodies in Parkinson's disease
15. Neuropathology of Parkinson's disease
16. The Lewy body in Parkinson's disease
17. Ultrastructure of Lewy bodies in the stellate ganglion
18. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brainstem in Lewy bodies
19. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease
20. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease
21. Multiple-system atrophy: A new α-synuclein disease?
22. α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals filamentous multi-protein components
23. Filaments of Lewy bodies contain insoluble cytoskeletal elements
24. The centenary of Friederich H. Lewy 1885-1950
25. Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and α-synucleinopathies
26. Spectrofiuorometric studies of the lipid probe, Nile red
27. Diffuse Lewy body disease as substrate of primary lateral sclerosis
28. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies
29. Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains
30. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
31. Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
32. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments
33. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
34. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
35. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
36. Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia
37. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
38. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
39. Colloid (hyaline) inclusion bodies in the central nervous system: Their presence in the substantia nigra is diagnostic of Parkinson's disease
40. Mutation in the α-synuclein gene identified in families with Parkinson's disease
41. Esophageal Lewy bodies associated with ganglion cell loss in achalasia: Similarity to Parkinson's disease
42. Ultrastructural observations in Parkinsonism
43. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
44. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
45. Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-Parkinsonian patient
46. Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses
47. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
48. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy